GlassScriptPhysician profile
Herrick Duong
NPI 1255959359
$9,743.18
in general payments reported to CMS, 2019-2025
23 companies · $1,686 in 2025
The $1,686 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $729 · 2022: $1,916 · 2023: $2,979 · 2024: $2,435 · 2025: $1,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,226 · Travel and Lodging: $1,873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,225.74 |
| Travel and Lodging | $1,872.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,003.18 | 2021-2025 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Bausch & Lomb Americas INC. | $1,896.97 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Coopervision INC. | $1,299.27 | 2022-2025 | Misight Contact Lens, Clariti Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $693.21 | 2022-2025 | Acuvue |
| Oyster Point Pharma, INC. | $516.21 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $496.93 | 2022-2024 | Cequa |
| Tarsus Pharmaceuticals, INC. | $367.43 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $351.52 | 2023 | |
| Abbvie INC. | $348.92 | 2022-2025 | Vuity |
| Astellas Pharma US INC | $264.99 | 2024-2025 | Izervay |
| Aerie Pharmaceuticals, INC. | $239.01 | 2021 | |
| Sight Sciences, INC. | $148.42 | 2022 | |
| Mallinckrodt Hospital Products INC. | $146.18 | 2024 | Acthar |
| Amgen INC. | $143.27 | 2024 | |
| Horizon Therapeutics Plc | $125.00 | 2023 | Tepezza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $125.00 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2021 | |
| Dompe US, INC. | $121.85 | 2023 | Oxervate |
| Glaukos Corporation | $106.32 | 2021 | |
| Visioneering Technologies, INC. | $76.60 | 2025 | |
| Visionix USA, INC | $71.43 | 2022 | |
| Rxsight INC | $68.41 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Lkc Technologies, INC. | $8.06 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herrick Duong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.